Your session is about to expire
← Back to Search
Triple Inhaler Therapy for COPD After Hospitalization (IKANOS Trial)
IKANOS Trial Summary
This trial looks at how a triple therapy affects COPD patients after hospital discharge to reduce readmissions.
IKANOS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowIKANOS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IKANOS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have passed away either during or before leaving the hospital.You are currently using a specific type of inhaler medication in addition to Breztri.You are willing to use Breztri as a regular inhaler medication as instructed by your doctor.You have been using a specific type of inhaler treatment for chronic lung disease or other conditions in the past 6 months.
- Group 1: Breztri
- Group 2: External Comparator - Non-Triple
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Am I able to join this clinical research initiative?
"Participants who are 40 and 100 years old with chronic obstructive pulmonary disease can be accepted into this trial. There is a goal of 1000 enrollees in total."
Has Breztri been granted clearance by the FDA?
"This treatment is approved, therefore it has attained a score of 3 for safety."
Are there multiple research centers conducting this investigation in North America?
"This research is currently happening in 7 centers, including those based out of Peoria, Salisbury and Mount Clemens. It would be prudent to select the facility nearest you in order to minimize travel-related challenges if chosen as a participant."
Does this study have any age restrictions, particularly for younger participants?
"As outlined in the inclusion criteria, only individuals aged 40-100 will be considered for participation. There are 13 separate trials that cater to patients under 18 and 275 studies catering to those over 65."
Is enrollment for this examination still available?
"Clinicaltrials.gov indicates that no new patients are being recruited for this trial at the present moment. This medical study was initially posted on September 25th 2023 and last updated on July 21st of the same year. Although not enrolling any additional participants, there are 281 other clinical trials currently in search of volunteer candidates."
Share this study with friends
Copy Link
Messenger